Wilson et al. also identified similar cell types and cell-specific differentially expressed genes in the kidney cortex between DKD patients and controls by snRNA-seq and validated that glucocorticoid receptor inhibition might mitigate the adverse metabolic effects of DKD by integrating single nucleus ATAC sequencing analysis [45]. The gene discussed is NR3C1; the disease is diabetic kidney disease.